Skip to main content

Glucose-6-phosphate dehydrogenase deficiency and psychoses

  • Chapter
Plasticity and Morphology of the Central Nervous System

Abstract

Glucose-6-phosphate-dehydrogenase (G6PD) catalyzes the first step in the hexose monophosphate (HMP) shunt. This pathway serves to supply the cell with NADPH, the most important function being probably the maintainance of glutathione (GSH) in the reduced state. G6PD deficiency is the most common disease-producing enzyme deficiency of human beings, affecting about one hundred million people throughout the world. G6PD is subject to different mutations, and more than two hundred variants have been reported. Some of these cause a deficiency of enzyme activity in erythrocytes, leading to hemolitic anemia, usually upon exposure to an offending drug or toxin. Hemolysis may also occur during infection, diabetic acidosis, or when there is no known inciting cause. Some persons, perhaps carrying an additional genetic defect, show a particular sensitivity to fava beans (favism), whether upon ingestion or exposure to pollen. Different genetic variants of G6PD may have effects in tissues other than the erythrocytes, including the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dern, RJ, Glynn, MF and Brewer, GJ (1962). Studies on the influence of hereditary G6PD deficiency in the expression of schizophrenic patterns. Clin Res, 10, 80

    Google Scholar 

  2. Dern, RJ, Glynn, MF and Brewer, GJ (1963). Studies on the correlation of the genetically determined trait, glucose-6-phosphate dehydrogenase deficiency, with behavioral manifestations in schizophrenia. J Lab Clin Med, 62, 319

    PubMed  CAS  Google Scholar 

  3. Bowman, JE, Brewer, GJ, Frischer, H, Carter, JL, Eisenstein, RB and Bayrakci, C (1965). A re-evaluation of the relationship between glucose-6-phosphate dehydrogenase deficiency and the behavioral manifestations of schizophrenia. J Lab Clin Med, 65, 222

    PubMed  CAS  Google Scholar 

  4. Fieve, RR, Brauninger, G, Fleiss, J and Cohen, G (1965). Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. J Psychiat Res, 3, 255

    Article  PubMed  CAS  Google Scholar 

  5. Nasr, SJ (1976). Glucose-6-phosphate dehydrogenase deficiency with psychosis. Arch Gen Psychiat, 33, 1202

    PubMed  CAS  Google Scholar 

  6. Nasr, SJ, Altman, E, Pscheidt, G and Meltzer, HY (1982). Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study. Biol Psychiatr, 17, 925

    CAS  Google Scholar 

  7. Bocchetta, A, Del Zompo M, Martis, G and Corsini, GU (1985). Glucose-6-phosphate dehydrogenase deficiency in a Sardinian psychiatric population. IVth World Congress of Biological Psychiatry, abs. 231. 1, p. 183

    Google Scholar 

  8. Spitzer, RL, Endicott, J and Robins, E (1977). Research Diagnostic Criteria, 3rd edition. ( New York: Biometric Research, New York State Psychiatric Institute )

    Google Scholar 

  9. Kornberg, A and Horecker, BL (1955). Glucose-6-phosphate de- hydrogenase. In: Colowick, SP and Kaplan, NO (eds.) “Methods in Enzymology”. p. 323. ( New York: Academic Press )

    Chapter  Google Scholar 

  10. Löhr, GW and Waller, HD (1974). Glucose-6-phosphate dehydrogenase. In: Bergmeyer, HU (ed.) “Methods of Enzymatic Analysis”. p. 636. ( New York: Academic Press )

    Google Scholar 

  11. Siniscalco, M, Bernini, L, Filippi, G, Latte, B, Meera Khan, P, Piomelli, S and Rattazzi, M (1966). Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. Bull WHO, 34, 379

    PubMed  CAS  Google Scholar 

  12. Meijer, A (1984). Psychiatric problems of children with glucose -6-phosphate dehydrogenase deficiency. Int J Psychiatr Med, 14, 207

    Article  Google Scholar 

  13. Gaetani, G, Salvidio, E, Pannacciulli, I, Ajmar, F and Paravidino, G (1970). Absence of haemolytic effects of L-Dopa on transfused G6PD-deficient erythrocytes. Experientia, 26, 785

    Article  PubMed  CAS  Google Scholar 

  14. Goodwin, FK, Murphy, DL, Brodie, HKH and Bunney, WE (1971). Levodopa: alterations in behavior. Clin Pharmacol Ther, 12, 383

    PubMed  CAS  Google Scholar 

  15. Mendlewicz, J, Yahr, F and Yahr, MD (1976). Psychiatric disorders in Parkinson’s disease treated with L-dopa: a genetic study. In: Birkmayer, W and Hornykiewicz, 0 (eds.) “Advances in Parkinson-ism”. p. 103. ( Basle: Editiones “Roche” )

    Google Scholar 

  16. Hothersall, JS, Greenbaum, AL and McLean, P (1982). The functional significance of the pentose phosphate pathway in synaptosomes: protection against peroxidative damage by catecholamines and oxidants. J Neurochem, 39, 1325

    Article  PubMed  CAS  Google Scholar 

  17. Tabakoff, B, Groskopf, W, Anderson, R and Alivisatos, SGA (1974). Biogenic aldehyde metabolism, relation to pentose shunt activity in brain. Biochem Pharmacol, 23, 1707

    Article  PubMed  CAS  Google Scholar 

  18. Maker, HS, Weiss, C, Silides, DJ and Cohen, G (1981). Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J Neurochem, 36, 589

    Article  PubMed  CAS  Google Scholar 

  19. Engel, GL, Romano, J and Ferris, EB (1947). Effect of quinacrine (atabrine) on the central nervous system. Clinical and electroencephalografic studies. Arch Neurol Psychiat, 58, 337

    PubMed  CAS  Google Scholar 

  20. Tarantino, LM and Hotta, SS (1974). Quinacrine stimulation of glutathione reduction dependent on the presence of a particulate brain subfraction. Proc Soc Exp Biol Med, 147, 887

    PubMed  CAS  Google Scholar 

  21. Risch, N and Baron, M (1982). X-linkage and genetic heterogeneity in bipolar-related major affective illness: reanalysis of linkage data. Ann Hum Genet, 46, 153

    Article  PubMed  CAS  Google Scholar 

  22. Thomson, G and Bodmer, W (1977). The genetic analysis of HLA and disease associations. In: Dausset, J and Svejgaard, A (eds.) “HLA and Disease”. p. 84. ( Copenhagen: Munksgaard )

    Google Scholar 

  23. Hodge, SE and Spence, MA (1981). Some epistatic two-locus models of disease. II. The confounding of linkage and association. Am J Hum Gen, 33, 396

    CAS  Google Scholar 

  24. Risch, N (1983). A general model for disease-marker association. Ann Hum Gen, 47, 245

    Article  CAS  Google Scholar 

  25. Mendlewicz, J, Linkowski, P and Willmotte, J (1980). Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis. Br J Psychiat, 137, 337

    Article  CAS  Google Scholar 

  26. Del Zompo, M, Bocchetta, A, Goldin, LR and Corsini, GU (1984). Linkage between X-chromosome markers and manic-depressive ilness. Acta Psychiatr Scand, 70, 282

    Article  PubMed  Google Scholar 

  27. Baron, M, Risch, N, Hamburger, R, Mandel, B, Kushner, S, Newman, M, Drumer, D and Belmaker, RH (1987). Genetic linkage between X-chromosome markers and bipolar affective illness. Nature, 326, 289

    Article  PubMed  CAS  Google Scholar 

  28. Risch, N,Baron, M and Mendlewicz, J (1986). Assessing the role of X-linked inheritance in bipolar-related major affective disorder. J Psychiatr Res, 20, 275

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bocchetta, A., Del Zompo, M., Corsini, G.U. (1990). Glucose-6-phosphate dehydrogenase deficiency and psychoses. In: Cazzullo, C.L., Sacchetti, E., Conte, G., Invernizzi, G., Vita, A. (eds) Plasticity and Morphology of the Central Nervous System. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0851-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0851-2_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6870-3

  • Online ISBN: 978-94-009-0851-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics